Pay in 4 interest-free payments of $40.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
310: 490-493
the VSIG3 has been reported to as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas
which is closely related to the occurrence and development of squamous cell carcinoma
NQEQVSPLTLLKLGNQEPGGQTALKSPPGVCSRDPTPEQTHRLARAMMAFTADLFSLVAQTSTCPNLILSPLSVALALSHLALGAQNHTLQRLQQVLHAGSGPCLPHLLSRLCQDLGPGAFRLAARMYLQKGFPIKEDFLEQSEQLFGAKPVSLTGKQEDDLANINQWVKEATEGKIQEFLSGLPEDTVLLLLNAIHFQGFWRNKFDPSLTQRDSFHLDEQFTVPVEMMQARTYPLRWFLLEQPEIQVAHFPFKNNMSFVVLVPTHFEWNVSQVLANLSWDTLHPPLVWERPTKVRLPKLYLKHQMDLVATLSQLGLQELFQAPDLRGISEQSLVVSGVQHQSTLELSEVGVEAAAATSIAMSRMSLSSFSVNRPFLFFIFEDTTGLPLFVGSVRNPNPSAPRELKEQQDSPGNKDFLQSLKGFPRGDKLFGPDLKLVPPMEEDYPQFGSPKGGGGSHHHHHHHHHH
USP14 Protein Human ELISA Kit 310: 490-493Product Specification Species Human Synonyms Ubiquitin carboxyl terminal hydrolase 14,Deubiquitinating enzyme 14,Ubiquitin thioesterase 14,Ubiquitin specific processing protease 14 Accession P54578 Amino Acid Sequence Q96 Q494 end Expression System E. coli Molecular Weight 47. 6 KDa Purity 95% by SDS PAGE Endotoxin <0. 01EU g Conjugation Unconjugated Tag His Tag Physical Appearance Liquid Storage Buffer 50 mM Tris HCl (pH 7. 5), 250 mM NaCl, 5%